Back to Journals » Clinical Ophthalmology » Volume 8

The impact of different algorithms for ideal body weight on screening for hydroxychloroquine retinopathy in women
Authors Browning D, Lee C, Rotberg D
Received 20 April 2014
Accepted for publication 27 May 2014
Published 24 July 2014 Volume 2014:8 Pages 1401—1407
DOI https://doi.org/10.2147/OPTH.S66531
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
David J Browning, Chong Lee, David Rotberg
Charlotte Eye, Ear, Nose and Throat Associates, Charlotte, North Carolina, NC, USA
Purpose: To determine how algorithms for ideal body weight (IBW) affect hydroxychloroquine dosing in women.
Methods: This was a retrospective study of 520 patients screened for hydroxychloroquine retinopathy. Charts were reviewed for sex, height, weight, and daily dose. The outcome measures were ranges of IBW across algorithms; rates of potentially toxic dosing; height thresholds below which 400 mg/d dosing is potentially toxic; and rates for which actual body weight (ABW) was less than IBW.
Results: Women made up 474 (91%) of the patients. The IBWs for a height varied from 30–34 pounds (13.6–15.5 kg) across algorithms. The threshold heights below which toxic dosing occurred varied from 62–70 inches (157.5–177.8 cm). Different algorithms placed 16%–98% of women in the toxic dosing range. The proportion for whom dosing should have been based on ABW rather than IBW ranged from 5%–31% across algorithms.
Conclusion: Although hydroxychloroquine dosing should be based on the lesser of ABW and IBW, there is no consensus about the definition of IBW. The Michaelides algorithm is associated with the most frequent need to adjust dosing; the Metropolitan Life Insurance, large frame, mean value table with the least frequent need. No evidence indicates that one algorithm is superior to others.
Keywords: hydroxychloroquine, ideal body weight, actual body weight, toxicity, retinopathy, algorithms
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.